Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
February 16, 2021

Coronavirus company news summary – WHO approves two additional forms of the AstraZeneca Covid-19 vaccine – Novavax and SK Bioscience collaborates on Covid-19 vaccine in South Korea

By Allie Nawrat

The World Health Organization (WHO) has approved two additional versions of the AstraZeneca/University of Oxford Covid-19 vaccine for emergency use. The vaccines in question are being produced by AstraZeneca-SKBio in South Korea and the Serum Institute of India. This approval allows the vaccines to be rolled out globally with the help of the COVAX facility.

According to reports by RIA news agency, India is likely to approve Russia’s Sputnik V vaccine to tackle Covid-19. The Russian vaccine candidate is currently being tested for safety and efficacy in small human trials being conducted in India. India’s Dr Reddy’s Laboratories and the Russian Direct Investment Fund (RDIF) have been collaborating to conduct these trials.

Novavax and SK Bioscience have expanded their  collaboration and license agreement for 40 million doses of the former’s Covid-19 vaccine in South Korea. In addition, SK Bioscience has obtained a license to increase the production capacity and supply to the South Korean government.

According to the German biotech firm Leukocare, a pan-European consortium  developing a Covid-19 vaccine is currently in discussion with big pharma to receive support for late-stage development of the jab and also to ramp up manufacturing. Leukocare has collaborated with Italy’s ReiThera and Belgium’s Univercells on an adenovirus vaccine candidate, which is similar to Covid-19 vaccines being developed by AstraZeneca/Oxford and Johnson & Johnson.



Content from our partners
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy